Chul Kim

Chul Kim, MD

-

Faculty

Financial Disclosure

NA

Employee

Royalties

Grant Or Contract

Patent Beneficiary

Executive Role

Ownership Interest

Professional Service

Other

Speaker

Independent

Contractor

AstraZeneca; Novartis; Regeneron; Johnson & Johnson; Genentech; Daiichi Sankyo; Gilead; MacroGenics; Boehringer Ingelheim; ORIC Pharmaceuticals; BlossomHill Therapeutics; EMD Serono, Pheon Therapeutics

Researcher

AstraZeneca, Daiichi Sankyo, Eisai, Regeneron, Sanofi, Takeda Pharmaceuticals, Johnson & Johnson, PineTree Therapeutics, Boehringer Ingelheim, Bristol Myers Squibb, Bicycle Therapeutics, Bayer, Onviv, Bio-Thera, Molecular Partners, Partner Therapeutics, Natera, Guardant, EMD Serono, Mariana Oncology, Nuvation Bio, Delfi Diagnostics, Pfizer, CARIS, Henlius, BlossomHill Therapeutics

Consultant

As above in the Consultant section

Advisor